Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Effect of SFX-01 on proliferation of human glioblastoma cell lines

steve | 16 September 2021

Categories:

Post navigation

← Voting on AGM resolutions

Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma →

Privacy Policy
Data Protection Complaints Handling Process
Sitemap

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.